活動
1886 人關注
-
Jon McMillan 已分享It was an honor to attend the “Healthy Taiwan” national forum, where government and healthcare leaders shared progress on initiatives to strengthen healthcare, including efforts to reduce cancer by one-third by 2030, promote healthy living, and support an aging population. It was encouraging to see progress across these focus areas—particularly in cancer, where screening rates have increased significantly. Proud to be part of Hologic and to support these efforts through AmCham Taiwan and the public healthcare committee.Jon McMillan 已分享Sunday afternoon at the Healthy Taiwan National Forum was inspiring. It was encouraging to hear about government planning and investment focused on not just living longer, but living healthier for a longer time. Taiwan’s global ranking as top in healthcare is well earned. Great to have many of our AmCham members join the event as well. Jon McMillan Hugh Yang Jason Yang 葉素秋Cellina, Yeh Mark Little Wang Kai-Hao Iris Li Ashley (Pei Jung) Li Eric (Meng-Wei) H. Claire Chang Evelyn Chang
-
Jon McMillan 已分享Cervical cancer prevention & diagnostics remains a critical focus across Emerging Asia, where we continue working to advance women’s health through technology and innovation. Recently, we hosted a series of educational events across Vietnam, Thailand, Taiwan, India, and Singapore focused on the impact using digital cytology and HPV screening practices. The Team also held our 1st virtual workshop with 10 countries on digital cytology, where we showcased Genius™ digital imaging and AI‑driven morphology analysis and explored how these technologies can support routine cytology workflows. Hologic’s Genius™ Digital Diagnostics System represents an important step forward for cytology. By combining high‑resolution digital imaging with AI‑based morphology analysis, it helps labs review slides more efficiently, supports consistent interpretation, and enables greater collaboration, education, and remote consultation capabilities that are increasingly important as healthcare systems modernize. Together with clinicians and laboratory partners across the region, we are helping expand access to more advanced screening approaches that support earlier detection and better outcomes for women. #CervicalCancerPrevention #WomensHealth #DigitalCytology #HPVScreening #MedTech #HealthcareInnovation, #hologic
-
Jon McMillan 已分享I’m pleased to see that for the 5th year running, Taiwan has come top of the Hologic Global Women’s Health Index, this year with a score of 69. This compares to the global average of 54. But the consistent high scores hide a more telling story on preventive care. While the scores for emotional health and individual health have increased, those for preventive care still have an opportunity to further move higher which is why Hologic Taiwan continues to work with stakeholder, partners and local communities on initiatives to further increase cervical cancer, infectious diseases, and breast cancer through access, education & awareness, and technology advancement. Thank you to all who have been part of this evolving healthcare journey in Taiwan and around the region to advance healthcare and especially for women’s health. If you’d like to explore the data further visit: https://lnkd.in/gpatjdbb #healthytaiwan, #hologic, #globalwomenshealthindex, #preventivecare, #breastcancer, #cervicalcancer, #taiwanhealthcare
-
Jon McMillan 已分享Recently the research studies from the Lehigh University scholar students was published in the Perspectives on Business and Economics Journal titled “Resilient Taiwan” where I was invited to write the introduction and share my insights on Taiwan’s business, healthcare, culture & society and technology and innovation on a place that has been my home and center of my professional life for over 25 years. Today, Taiwan stands at a critical point in its growth and global position in trade, investments, and technology. This reality made supporting the Lehigh University Martindale program in Taiwan even more significant, given the opportunity to share with the scholars my Taiwan experiences and perspectives. The conversations during their visit were engaging and profound, covering Taiwan's aging society, its national healthcare system, economic growth and foreign investment climate, alternative energy and innovative technologies such as AI and semiconductors, and women's programs and rights. Thank you to #lehighuniversity, #martindalescholars, #resilienttaiwan, #hologic and congratulations to Martindale Scholar students where you all have a tremendous opportunity to advance your connection to Taiwan and return to contribute to its resilient future. Trisha Alexy Beth Dolan Cheryl Matherly https://lnkd.in/gNNmmcDt
-
Jon McMillan 已分享Healthcare access, prevention & treatment technology, and patient & family care have always been at the forefront here in Taiwan; and it is inspiring to have these critical platforms such as the “Healthy Aging Forum” bringing together leaders to discuss progress and also address what lies ahead. Tremendous Appreciation to Amcham, the planning team, and the public health committee for making this event a standard for strategies & plans-for-action in Taiwan. Go “Healthy Taiwan”Jon McMillan 已分享🌿 2026 𝐇𝐞𝐚𝐥𝐭𝐡𝐲 𝐀𝐠𝐢𝐧𝐠 𝐅𝐨𝐫𝐮𝐦 | 𝐍𝐚𝐯𝐢𝐠𝐚𝐭𝐢𝐧𝐠 𝐚 𝐒𝐮𝐩𝐞𝐫-𝐀𝐠𝐞𝐝 𝐒𝐨𝐜𝐢𝐞𝐭𝐲 With Taiwan officially entering a super-aged society in December 2025, the conversation around aging is moving beyond longevity toward a broader focus on health, dignity, and resilience across the lifespan. As demographic shifts accelerate, addressing aging-related challenges calls for coordinated efforts across healthcare, policy, innovation, and society as a whole. To help advance this dialogue, AmCham Taiwan and AIT convened the 2026 Healthy Aging Forum, bringing together government representatives, healthcare leaders, industry experts, and researchers to explore how Taiwan can navigate the challenges—and opportunities—of a super-aged society through meaningful public-private collaboration. 💡 𝐊𝐞𝐲 𝐭𝐡𝐞𝐦𝐞𝐬 𝐟𝐫𝐨𝐦 𝐭𝐡𝐞 𝐟𝐨𝐫𝐮𝐦 𝐢𝐧𝐜𝐥𝐮𝐝𝐞𝐝: • Building sustainable healthcare systems for an aging population • Strengthening prevention and chronic disease management across the life course • Leveraging medical innovation and digital health to support healthy aging • Enhancing care delivery models for patients, families, and caregivers • Reframing aging as an opportunity for societal resilience and long-term growth We thank all speakers and participants for their thoughtful insights and contributions. We are also grateful to our 2026 forum sponsors — Amway 安麗台灣, Edwards Lifesciences, MSD Taiwan, Novo Nordisk, Pfizer, and Vantive — for their continued support and commitment to advancing healthy aging in Taiwan. With the perspectives shared at this forum, AmCham Taiwan remains committed to serving as a platform for dialogue and partnership, working alongside the public and private sectors to help shape a healthier, more sustainable future for Taiwan’s aging society.
-
Jon McMillan 已分享Recently our Emerging Asia Diagnostics Commercial Partners and Team came together to discuss business strategies and plans for 2026. Some great discussions to further these plans and sharing across the region on cervical health and molecular infectious disease testing. What stood out for me personally was the connections and communication amongst the entire Team working with the common goal to further understand key issues, opportunities, solutions in these diagnostics testing disease areas for increasing screening, patient access, thought-leadership, and bringing new digital screening technologies to market. While we have done this in the past, the deeper focus and open discussions have positioned us for greater success in 2026. A Thank You to our entire Team and Commercial Partners for 2025 and for the opportunity we have ahead to make a difference in cervical health and infectious disease testing. #hologic, #diagnosticsolutions, #cervicalhealth, #infectiousdiseasetesting, #womenshealth, #digitaldiagnostics, #businesspartners
-
Jon McMillan 已分享Business partnering and ensuring we have optimal & sustainable support, process, and strategic plans are critical for further enabling our Customer Experience Team success. Thank you to our functional teams and recent visits to Taiwan from our international & regional teams as we work together with our business partners and customers on regulatory, quality, applications, and medical affairs strategies as we continue our growth journey providing solutions in molecular & cervical health diagnostics, breast cancer screening & detection, and bone density care across our Hologic portfolio making a positive difference here in Taiwan. #businesspartnering, #taiwanhealthcare, #hologic, #onehologic, #healthytaiwan, #growthstrategies
-
Jon McMillan 已分享A privilege for Hologic to be a partner with the Taiwan Breast Cancer Alliance (TBCA) as we came together to celebrate breast cancer awareness month and importantly recognize the many efforts from the “Healthy Taiwan” initiative which lowered the screening age to 40yrs (incr to 74yrs) and also share how Taiwan continues to focus on increasing screening through greater access and mobility to healthcare facilities while also furthering programs focusing on the importance of women being screened earlier. Thank you to the Taiwan Breast Cancer Alliance and All who continue in this journey to win against all cancers! #hologic, #taiwanhealthcare, #breastcancer, #breastcancerawareness, #taiwanbreastcanceralliance, #hologictaiwan
-
Jon McMillan 已轉發Jon McMillan 已轉發Ready for challenges and saves more lives? Check out this job at Hologic, Inc.: FSE and Sr. FSE. Come join us!! https://lnkd.in/gqet9Udx https://lnkd.in/gaTCSvYf
-
Jon McMillan 已按讚Jon McMillan 已按讚Our APAC team recently hosted a Breast Imaging Clinical Immersion Program, welcoming radiologists from Hong Kong to Hologic’s Centers of Excellence, Changi General Hospital and Singapore General Hospital. Focused on stereotactic biopsy, contrast-enhanced #mammography and contrast-enhanced biopsy, the program combined live procedure observation, case discussions and practical workflow sharing. We extend our sincere thanks to everyone who attended this event, with a shared goal of advancing #BreastImaging through collaboration and elevating standards of care for women across the region. #ClinicalEducation #HealthcareCollaboration
-
Jon McMillan 已按讚Jon McMillan 已按讚Great to run into DG Chen LianYu Chen at COMPUTEX and snap a picture with her and Jon McMillan.
-
Jon McMillan 已按讚Jon McMillan 已按讚Yesterday I wrapped my first Robotics Summit & Expo. Two full days of learning from people building the future of physical AI, making new connections, and getting a first-hand look at the technologies pushing the field forward. The energy was real, and so was the talent in the room. But here's my honest takeaway: there's still a significant gap between a demo and a robot doing real work alongside humans. One question stuck with me from yesterday morning's keynote: Is your robot "worthy"? Worthy of operating next to people. Worthy of being trusted with a task that actually matters. While walking the floor, I noticed how few robots were genuinely working versus posing for photos (guilty as charged 🙂). This is why safety has to be a first principle, not an afterthought. When a robot shares space with a human and handles real tasks, stability, reliability, and safety aren't features - they're the price of admission. At TACTUS AI, that's the standard we're building to. We're developing humanoid lab assistants designed to take on the repetitive, pre-analytical work in regulated laboratory environments - so skilled scientists can focus on what they do best. Not flashy. But built to actually work, safely and reliably, in some of the most demanding settings in healthcare and diagnostics. The future is genuinely exciting. But it'll be earned by the teams who treat "worthy" as the bar. Grateful for everyone who shared their time and ideas this week. #Robotics #PhysicalAI #HealthcareInnovation #Diagnostics #LabAutomation #HumanoidRobots #RoboticsSummit Jarin Foster Andrew Ward, MS Emily Warenda James Fox Chris Vitale Jim Hammerand Jiaxi Kevin Su
-
Jon McMillan 已按讚Jon McMillan 已按讚Over the last several years, I’ve become increasingly convinced that in MedTech, service is no longer a support function — it’s a strategic growth engine. When you lead a global recurring revenue business at scale, the conversation quickly becomes much bigger than break/fix response times. It’s about: * Customer retention * Installed-base strategy * Operational execution * Predictable growth * Digital enablement * AI-driven workflow transformation * And ultimately, customer trust The organizations that will lead the next decade are the ones that successfully connect commercial strategy, operations, technology, and customer experience into a unified operating model. At Hologic, our Global Service vision helps ground how we approach that responsibility every day: “One Team: passionate in what we do, trusted in action, delivering for the benefit of patients everywhere.” That vision is bigger than service alone. It reflects how we partner across teams, support our customers, and continue evolving how service creates value across the enterprise. In healthcare especially, uptime matters. Workflow matters. Responsiveness matters. Not just for business performance — but for the clinicians and patients depending on these systems every day. Grateful for the teams around the world who continue raising the bar and driving meaningful impact for our customers and the patients they serve. #Leadership #Operations #MedTech #CustomerExperience #RecurringRevenue #Transformation #HealthcareInnovation #OperationalExcellence
-
Jon McMillan 已按讚Jon McMillan 已按讚After two and a half meaningful years, I am closing my chapter with AmCham Taiwan. Serving as Director of Government Relations and Public Affairs has been one of the most rewarding experiences of my professional life. I have had the privilege of working alongside an exceptional team, dedicated member companies, government counterparts, policy leaders, and partners across Taiwan and the United States who care deeply about strengthening the economic, strategic, and people-to-people ties that define this relationship. I am especially grateful to the AmCham Taiwan leadership, Board of Governors, committees, and member companies for their trust and support throughout this journey. Together, we navigated complex policy issues, advanced constructive public-private dialogue, and contributed to conversations that matter for Taiwan’s competitiveness, resilience, and international engagement. This role has taught me that effective public affairs is not only about policy outcomes. It is also about trust, consistency, listening carefully, and building the kind of relationships that allow hard conversations to become productive ones. I will carry those lessons with me into the next chapter. As I move forward, I do so with deep appreciation for the journey past and genuine optimism for what lies ahead. Taiwan will continue to play a critical role in regional security, innovation, and global supply chains, and I remain committed to contributing to that broader mission in new ways. Thank you to everyone who has been part of this chapter. I am grateful for your leadership, friendship, mentorship, and support. Onward to new beginnings.
-
Jon McMillan 已按讚Jon McMillan 已按讚Globally, 1 in 20 women will be diagnosed with breast cancer, making earlier action more urgent than ever as we approach #ASCO26. The burden is rising, especially in low- and middle-income countries, and the need for transformative solutions has never been clearer. At AstraZeneca, we are focused on using innovation to enable earlier diagnosis and help ensure patients receive the right treatment sooner. This is critical to improving outcomes at scale. I’m looking forward to engaging with the oncology community at ASCO and translating insights into scalable solutions that can make a meaningful difference for patients globally, across diverse healthcare settings.
-
Jon McMillan 已按讚With AI compressing time to develop and breaking down barriers of differing data sets from the myriad universe of participants, it’s time to really see trade digitalization finally succeed!Jon McMillan 已按讚Mitigram is proud to announce the creation of our Global Advisory Board. This represents an exciting new chapter in our journey to advance digital trade finance and deliver greater value to the industry. Please join us in welcoming our new advisors: ✔️ Carl Wegner - A pioneer in trade digitalization ✔️ Meral Şengöz - A leading voice on trade finance transformation ✔️ Merisa Lee Gimpel - A powerhouse in fintech innovation As our CEO Joshua Kroeker puts it: "The collective expertise of Carl, Meral and Merisa is unmatched, and their insights will be a catalyst for our growth as we pursue strategic growth opportunities." 👉 Read more in our press release: https://lnkd.in/dGF7F9RC #Mitigram #Mitigram4Growth #Announcement #AdvisoryBoard
-
Jon McMillan 已按讚Jon McMillan 已按讚Can we close the gender health gap with technology? Tomorrow I’ll be joining Carla Quintana and Carlos Jover Micó on a panel led by Dr Alice McGee to explore this topic as part of the Health Revolution Congress in Barcelona. We’ll be looking at how technology can help to close the gaps that remain in awareness, access and affordability across the female health journey. Come and join us with your questions and opinions on what we could be doing differently to address the gap.
-
Jon McMillan 已按讚Proud to have led and organized this for Hologic EA, featuring SGH and CGH as centers of excellence. I always enjoy these collaborations and partnerships that drive meaningful clinical exchanges to better patients in our region. Programs like this strengthen Hologic’s position in women’s health and help raise the standard of breast imaging across our region. Thank you to all who supported! Dr Tammy Moey Dr Boon Chye Dr Ian Dr Rameysh Danovani Mahmood Dr H Shi Dr Clement Hologic team Kay Leung Mani Ching Sudeep Jain Gwen Hurley L. C. and ITS SCIENCE & MEDICAL PTE LTD (HQ)Jon McMillan 已按讚Our APAC team recently hosted a Breast Imaging Clinical Immersion Program, welcoming radiologists from Hong Kong to Hologic’s Centers of Excellence, Changi General Hospital and Singapore General Hospital. Focused on stereotactic biopsy, contrast-enhanced #mammography and contrast-enhanced biopsy, the program combined live procedure observation, case discussions and practical workflow sharing. We extend our sincere thanks to everyone who attended this event, with a shared goal of advancing #BreastImaging through collaboration and elevating standards of care for women across the region. #ClinicalEducation #HealthcareCollaboration
其他相似會員
探索更多貼文
-
瑞健醫療
SHL Medical joins KiSS Science 2025 for the first time! 🧪 Now in its seventh year, this nationwide initiative is organized by Taiwan’s National Science and Technology Council, and opens the doors of research institutes and companies to high school students. On December 5, 11, and 12, we will welcome students to our Taiwan-Liufu facility for a guided site tour and an insightful lecture on how science, engineering, and design come together in the development of autoinjectors. From early concepts and prototypes to large-scale manufacturing, students will see how innovation turns into devices that support patients worldwide. Our involvement in KiSS Science reflects SHL Medical’s global commitment to nurturing future STEM talent, from internships and apprenticeships to outreach initiatives worldwide. We’re excited to inspire the next generation of innovators and create opportunities for young talents to grow with us. ✨ #KiSSScience #STEMEducation #TalentDevelopment #InnovationInAction #GrowWithSHL
1 則回應 -
SynerGood 三人恆好
【專欄最新文章Latest Column：生醫傳播Biomedical】 According to the 2024 Healthcare and Medical Industry Annual Report, Taiwan’s biomedical industry reached a total output value of NT$773.9 billion, signaling significant market expansion and industrial momentum. However, behind this growth lies a critical challenge: while biomedical innovation is gaining high visibility, public understanding has yet to reach a profound level. This is a clear gap where technology attracts attention, but its actual impact and value remain unclear to the public. This is not merely a lack of information, but a sign that communication is lagging behind innovation. In this edition of SynerGood Selects, Iris identifies two challenges in biomedical communication: ▪️Strict regulatory frameworks lead to conservative communication, hindering a comprehensive articulation of technological breakthroughs. ▪️Public trust is not built on persuasion, but on a clear explanation of the institutional and regulatory context. As innovation transcends professional circles into the public discourse, "how we communicate" becomes the deciding factor in whether breakthrough technology can earn public understanding and trust. 根據《2024 醫療健康產業年度報告》指出，台灣生醫產業在2024年的總產值達7,739 億元，顯示市場與產業動能仍在持續擴張。在這令人振奮的數字背後，我們發現生醫創新雖然被大量看見，但社會對創新的認識與理解並沒有同步前進，這些創新正走進一個「被看見，卻不一定真正被理解」的階段。 這樣的落差，並非單純的資訊不足，而是傳播理解的機制還沒有跟上技術前進的速度。 在這期的恆好選讀中，三人恆好專案經理Iris分享了兩個生醫創新在走進大眾媒體的困難點： ▪️嚴謹的法規制度導致對外溝通趨於保守，創新技術難以被交代清楚 ▪️大眾傳播圈的信任並非建立於說服，而是需要來自清楚的制度脈絡說明 當創新技術不再只是專業內部的事，而成為大眾議題，「怎麼說」本身，就成了創新的生醫傳播能否成為大眾了解與信任的關鍵。 👇 Read the full article /閱讀完整文章👇 #SynerGood #SynerGoodSelects #Biomedical #BiomedicalInnovation #BiotechIndustry #StrategicCommunication #MarketInsights
1 則回應 -
Topcon Healthcare (DKSH VN)
🌟 STRATEGIC PARTNERSHIP TO ENHANCE SMART OPHTHALMOLOGY IN VIETNAM The signing ceremony of the strategic tripartite collaboration between DKSH Vietnam, Topcon Healthcare SEA (Japan) and Medical Saigon Group (MSG) has garnered significant media attention, with extensive coverage from reputable outlets including VTV, VnExpress, and CafeF,... 🔹 This partnership marks a significant milestone in elevating ophthalmic care standards in Vietnam: 🌐 DKSH – Asia’s leading Market Expansion Services provider, operating across 36 markets. With over 100 years of presence in Vietnam, DKSH has been instrumental in the development of various sectors, particularly healthcare. Topcon Healthcare stands as one of DKSH’s key strategic partners in ophthalmology. 🔬 Topcon Healthcare – A global leader in ophthalmic devices, delivering comprehensive solutions for diagnosis and clinical decision-making. Topcon specializes in advanced smart diagnostic technologies, offering high-precision imaging and digital instruments that empower accurate and efficient eye care. 👁️ Medical Saigon Group (MSG) – Established in 2004, MSG is one of Vietnam’s leading private healthcare systems and the operator of the Saigon Eye Hospital network - the largest eye care chain in the country. Managing 26 hospitals and clinics with over 1,600 medical professionals, MSG has served over 6 million patient visits and performed 2 million surgeries, affirming its leadership in delivering international-standard eye care. 💙 This collaboration underscores our shared commitment to upgrading the quality of eye care, integrating smart technology to safeguard vision, and empowering Vietnamese ophthalmologists with precise diagnostics and treatment solutions. --------------------------------- CÔNG TY TNHH DKSH VIỆT NAM 👉Mọi thắc mắc chi tiết xin vui lòng liên hệ: 🚨 Hotline: 0901138780 📱 Fanpage: https://lnkd.in/gJgin8g5 ✉️ Email: mdshop.vn@dksh.com 🌐 Website: https://mdshop.dksh.com.vn
-
Pacific Medical Systems Limited
At the Hong Kong International Medical Health Fair 2025, we were privileged to welcome Dr. Tony Ko, the then CEO of the Hong Kong Hospital Authority, and fellow healthcare leaders to our booth. The focus was on how portable innovation can transform primary care. Dr. Ko engaged with two key solutions: • Vscan Air Handheld Ultrasound: Bringing AI-assisted, specialist-level imaging to community clinics for faster, more accurate first assessments. • PowerBeat M3 AED: A revolutionary 0.7kg, pocket-sized defibrillator designed for true portability, enabling immediate cardiac response anywhere. This visit was a powerful affirmation that our technology directly supports the core goals of Hong Kong's Primary Healthcare Blueprint—to build a stronger, more accessible, and tech-enabled first layer of community health. We are proud to contribute to this vital mission. #PrimaryCare #HealthTech #HongKongHealthcare #MedicalInnovation #VscanAir #AED #FrontlineMedicine #CommunityHealth
-
BIOCORP
✨ At Biocorp, we are proud to see how Mallya has already contributed to this innovative partnership between Novo Nordisk and 카카오헬스케어 - kakaohealthcare. The expansion into obesity care illustrates how connected devices and digital ecosystems can empower patients with more personalized support, from diabetes to other chronic conditions. Together, we move forward in building a future of smarter, patient-centric healthcare.
-
JY BioMed
JY BioMed at 2025 Healthcare+ Expo Taiwan | December 4–7 We were honored to participate in the 2025 Healthcare+ Expo Taiwan, where JY BioMed presented our latest preclinical research in cell therapy, antibody engineering, and exosome-based science. The event brought together leading experts across biotechnology and healthcare, providing an inspiring platform for scientific exchange and collaboration. During the exhibition, our team showcased three research posters: 1️⃣ Preclinical Evaluation of Unmodified Gamma-Delta T Cells Our ongoing studies explore γδ T-cell biology, dose-dependent activity in tumor models, and safety parameters in vitro and in vivo. These findings remain at the preclinical stage and support our broader scientific understanding of allogeneic γδ T-cell platforms. 2️⃣ Mesenchymal Stem Cell–Derived Exosomes in Neurodegenerative Disease Research We presented data investigating MSC-derived exosomes and their potential biological roles in neurological models. The work includes biodistribution analyses, behavioral assessments, and tolerability studies in animal systems. All results reflect early-stage exploratory research. 3️⃣ Heavy-Chain Antibody and ADC Platform Targeting CEACAM6 We introduced a humanized heavy-chain antibody (HCAb) under evaluation for its binding characteristics, internalization behavior, and translational potential as an ADC candidate in preclinical cancer models. These data help guide our future scientific assessment and development planning. JY BioMed remains committed to responsible innovation and to communicating our research in alignment with global regulatory standards. We sincerely thank our collaborators, partners, and visitors who engaged with us throughout the expo. We look forward to continued dialogue and new opportunities for scientific collaboration. #JYBioMed #HealthcarePlusExpo #PreclinicalResearch #CellTherapyResearch #GammaDeltaTCells #ExosomeResearch #AntibodyEngineering #TranslationalScience #BiotechnologyInnovation #ResponsibleResearch #Biotech #Immunotherapy #CellTherapy #Exosomes #ADC #AntibodyTechnology #OncologyResearch #NeuroscienceResearch #HealthcareInnovation #LifeSciences #BiotechCommunity #ScientificCollaboration
-
Korea Biomedical Review
https://lnkd.in/geYvhS2s UCB Korea General Manager Edward Lee spoke about the company’s renewed focus on patient access, reimbursement strategy and Korea’s growing role in global clinical development. In the interview, Lee emphasized that bringing innovative therapies to patients requires more than regulatory approval, particularly in rare and intractable diseases where reimbursement can determine real-world access.